SIGLEC15 and neoplasm: Combined with the previous findings, we speculated that the elevated SEMA5B may interfere with SIGLEC15 expression through some unknown mechanism, thus affecting the immune effect of cytotoxic T cells and ultimately prolonging the survival of tumor patients.